Kumar Ramesh

Avg. Two Year Performance

(87%) Avg. Purchase Return
(37%) Compound
89% Avg. Sale Return
37% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(< 1%)(2%)(2%)(76%)(87%)
Purchase Success Rate1 of 21 of 21 of 20 of 20 of 2
Average Sale Return42%58%62%73%89%
Sale Success Rate1 of 31 of 31 of 31 of 31 of 3

Traws Pharma, Inc.

Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 102.23K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Ocugen, Inc.

Drugs » Biotechnology

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--